As of May 2022 Swedish Orphan Biovitrum has a market cap of $6.36 Billion. This makes Swedish Orphan Biovitrum the world's 1946th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $6.18 B | 2.35% |
2021 | $6.03 B | 0.95% |
2020 | $5.98 B | 22.93% |
2019 | $4.86 B | -16.12% |
2018 | $5.80 B | 58.26% |
2017 | $3.66 B | 15.88% |
2016 | $3.16 B | -26.16% |
2015 | $4.28 B | 56.91% |
2014 | $2.73 B | -1.32% |
2013 | $2.76 B | 85.28% |
2012 | $1.49 B | 515.96% |
2011 | $0.24 B | -60.28% |
2010 | $0.61 B | 52.82% |
2009 | $0.39 B | 43.16% |
2008 | $0.27 B | -48.04% |
2007 | $0.53 B | -29.28% |
2006 | $0.75 B |
On May 15th, 2022 the market cap of Swedish Orphan Biovitrum was reported to be: